Increased risk of cardiovascular and renal disease, and diabetes for all women diagnosed with gestational diabetes mellitus in New Zealand—A national retrospective cohort study

Barbara M. Daly,Zhenqiang Wu,Krishnarajah Nirantharakumar,Lynne Chepulis,Janet A. Rowan,Robert K. R. Scragg
DOI: https://doi.org/10.1111/1753-0407.13535
IF: 4.53
2024-04-11
Journal of Diabetes
Abstract:Highlights Women diagnosed with gestational diabetes were significantly more likely to develop renal disease, have a major cardiovascular event, and develop hypertension and dyslipidemia following delivery compared with women without diabetes in pregnancy. The risk of developing type 2 diabetes for these women remains 20 times higher than for women without diabetes in pregnancy, despite knowledge of this association for over 50 years. European women diagnosed with gestational diabetes have the highest risk of developing type 2 diabetes compared with Māori, Pacific, and Asian women. Background Gestational diabetes mellitus increases the risk of developing type 2 diabetes. The aim of this study is to compare cardiometabolic and renal outcomes for all women in New Zealand with gestational diabetes (2001–2010) with women without diabetes, 10–20 years following delivery. Methods A retrospective cohort study, utilizing a national dataset providing information for all women who gave birth between 1 January 2001 and 31 December 2010 (n = 604 398). Adolescent girls <15 years, women ≥50 years and women with prepregnancy diabetes were excluded. In total 11 459 women were diagnosed with gestational diabetes and 11 447 were matched (for age and year of delivery) with 57 235 unexposed (control) women. A national hospital dataset was used to compare primary outcomes until 31 May 2021. Results After controlling for ethnicity, women with gestational diabetes were significantly more likely than control women to develop diabetes—adjusted hazard ratio (HR) 20.06 and 95% confidence interval (CI) 18.46–21.79; a first cardiovascular event 2.19 (1.86–2.58); renal disease 6.34 (5.35–7.51) and all‐cause mortality 1.55 (1.31–1.83), all p values
endocrinology & metabolism
What problem does this paper attempt to address?